REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Anterogen Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Anterogen Co.,Ltd. Profile Updated: May 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Anterogen Co.,Ltd. is an enterprise in South Korea, with the main office in Seoul. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 16, 2000. 32 (2025) employees currently work for Anterogen Co.,Ltd.. The latest financial highlights indicate a net sales revenue increase of 8.71% in 2025. Its total assets decreased by 23.97% over the same period. In 2025, Anterogen Co.,Ltd.’s net profit margin increased by 14.84%.

Headquarters
405 130 Digital-Ro, Geumcheon-Gu
Seoul; Seoul; Postal Code: 08589

Contact Details: Purchase the Anterogen Co.,Ltd. report to view the information.

Website: http://www.anterogen.com

Basic Information
Total Employees:
Purchase the Anterogen Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Anterogen Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Anterogen Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Anterogen Co.,Ltd. report to view the information.
Incorporation Date:
March 16, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
12.8%
Purchase this report to view the information.
8.1%
Purchase this report to view the information.
6.9%
Subsidiaries
Em-Tech Co.,Ltd.
Company Performance
Financial values in the chart are available after Anterogen Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.71%▲
Total Operating Revenue
8.4%▲
Operating Profit
35.67%▲
EBITDA
41.57%▲
Net Profit/Loss for the Period
40.08%▲
Total Assets
-23.97%▼
Total Equity
-20.66%▼
Operating Profit Margin
22.27%▲
Net Profit Margin
14.84%▲
Return on Equity (ROE)
0.51%▲
Quick Ratio
46.63%▲
Cash Ratio
1.56%▲

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
Viro Med Co.,Ltd.
 
Tego Science, Inc.
Clinomics Inc.
 
Anygen Co.,Ltd.
Intron Bio Technology Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo